Publications- Department of Haematology
2010
Journal Publications :1.Pathare AV, Taher A, Daar S. “Deferasirox (Exjade(R)) significantly
improves cardiac T2* in heavily iron-overloaded patients with betathalassemia major.” Ann Hematol. 2010 Apr;89(4):405-9.
http://dx.doi.org/10.1007/s00277-009-0838-z
2. Alkindi S, Al Zadjali S, Al Madhani A, Daar S, Al Haddabi H, Al
Abri Q,
Gravell D, Berbar T, Pravin S, Pathare A,Krishnamoorthy
R. Forecasting hemoglobinopathy burden through neonatal screening
in Omani neonates. Hemoglobin. 2010 Jan;34(2):135-44.
http://dx.doi.org/10.3109/03630261003677213
3.Battersby AJ, Knox-Macaulay HH, Carrol ED. Susceptibility to
invasive bacterial infections in children with sickle cell disease. Pediatr
Blood Cancer. 2010 Sep;55(3):401-6.
http://dx.doi.org/10.1002/pbc.22461
4. Alkindi S, Khan S, Riyami D, Farooqi M, Pathare A. Coexistence
of immune thrombocytopenic purpura and idiopathic membranous
glomerulonephritis successfully treated with rituximab. Platelets.
2010; 21(7): 575-7.
http://dx.doi.org/10.3109/09537104.2010.494744
5. Daar S, Ahmed S, Berdoukas V. Rapid Iron Loading in Heart and
Liver in a Patient with Transfusion Dependent Thalassaemia after Brief
Poor Compliance with Iron Chelation Therapy. Sultan Qaboos Univ Med
J. 2010 Dec;10(3):401-4.
6.Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar
S, Saned M, Cassaretti C, Cappellini M. Splenectomy and thrombosis:
the case of thalassaemia intermedia. J Thromb Haemost. 2010
Oct;8(10):2152-8. http://dx.doi.org/10.1111/j.15387836.2010.03940.x
7.Ali Taher, Khaled Musallam, Amal El-Beshlawy, Mehran Karimi,
Shahina Daar Khawla Belhoul, , Mohamed-SalahEldin Saned,
Giovanna Graziadei, Maria Cappellini. Age-related complications in
treatment-naïve patients with thalassemia intermedia. Br J Haematol.
2010 Aug;150(4):486-9. http://dx.doi.org/10.1111/j.13652141.2010.08220.x
8.Ali Taher, Abdullah Al Jefri, Mohsen Saleh Elalfy, Kusai Al Zir,
Shahina Daar, Diana Rofail, Jean François Baladi, Dany Habr, Ulrike
Kriemler-Krahn, and Amal El-Beshlawy. Improved Treatment
Satisfaction and Convenience with Deferasirox in Iron-Overloaded
Patients with -Thalassaemia: Results from the Escalator Trial. Acta
Hematologica, April 2010;123 (4): 220-225.
http://dx.doi.org/10.1159/000313447
9. Ali Taher, Khaled Musallam, Mehran Karimi, Amal El-Beshlawy,
Khawla Belhoul, Shahina Daar, Mohamed-SalahEldin Saned, AbdulHamid El- Chafic, Maria Fasulo, Maria Cappellini, Overview on
Practices in Thalassemia Intermedia Management Aiming for Lowering
Complication-rates Across a Region of Endemicity: the OPTIMAL CARE
study. Blood, 2010; 115: 1886-1892. http://dx.doi.org/10.1182/blood2009-09-243154
10.Muhmmed Suliman MA, Bahnacy Juma AA, Ali Almadhani AA,
Pathare AV, Alkindi SS, Uwe Werner F. Predictive value of
neutrophil to lymphocyte ratio in outcomes of patients with acute
coronary syndrome. Arch Med Res. 2010 Nov;41(8):618-22.
http://dx.doi.org/10.1016/j.arcmed.2010.11.006
11.Puig N, Pintilie M, Seshadri T, Al-Farsi K, Nagy T, Franke N, Tsang
R, Keating A, Crump M, Kuruvilla J. Different response to salvage
chemotherapy but similar post-transplant outcomes in patients with
relapsed and refractory Hodgkin's lymphoma. Haematologica. 2010
Sep;95(9):1496-502.
http://dx.doi.org/10.3324/haematol.2009.019943
12.Alkindi S, Al-Maini M, Pathare A. Clinical and laboratory
characteristics of patients with sickle-cell and autoimmune/connective
tissue diseases. Rheumatol Int. 2010 32(2), 373-378.
http://dx.doi.org/10.1007/s00296-010-1632-x
13.Aljurf M, Zaidi SZ, Hussain F, Ghavamzadeh A, Alimoghaddam K,
Jahani M, Mahmoud HK, Haddad A, Adil S, Ben Othman T, Sarhan MM,
Dennison D, Ibrahim A, Benchekroun S, Ayas M, Al Zahrani H, Al
Mohareb F, El Solh H. Status of hematopoietic stem cell
transplantation in the WHO Eastern Mediterranean Region (EMRO).
Transfus Apher Sci. 2010 Apr;42(2):169-75.
http://dx.doi.org/10.1016/j.transci.2010.01.012
14. Al-Khabori M, Minden MD, Yee KW, Gupta V, Schimmer AD,
Schuh AC, Xu W, Brandwein JM. Improved survival using an intensive,
pediatric-based chemotherapy regimen in adults with T-cell acute
lymphoblastic leukemia. Leukemia & Lymphoma. 2010;51(1):61-65.
http://dx.doi.org/10.3109/10428190903388376
15. Dalal B, Al Riyami A, Yenson P. Microangiopathic haemolytic
anaemia and hyposplenism in angiosarcoma. Br J Haematol. 2010
;151(5):413. http://dx.doi.org/10.1111/j.1365-2141.2010.08281.x
16. Mousa SA, Al Momen A, Al Sayegh F, Al Jaouni S, Nasrullah Z, Al
Saeed H, Alabdullatif A, Al Sayegh M, Al Zahrani H, Hegazi M, Al
Mohamadi A, Alsulaiman A, Omer A, Al Kindi S, Tarawa A, Al Othman
F, Qari M. Management of painful vaso-occlusive crisis of sickle-cell
anemia: consensus opinion. Clin Appl Thromb Hemost. 2010
Aug;16(4):365-76. http://dx.doi.org/10.1177/1076029609352661
17. Eosinophilia Case 5067 ASCP check Path, J.Ford, A.Z Al-Riyami,
Clinical Pathology 2010, Quarter 2
Conference Presentations
2010
1. Khabori MA, El-Emary M, Messner H, et al. Two-Digit Resolution
Typing Of Class-I Human Leukocyte Antigen (HLA) Does Not
Compromise Outcomes In Adults Undergoing Matched Unrelated
Allogeneic Bone Marrow Transplantation. Biology of blood and marrow
transplantation: Journal of the American Society for Blood and Marrow
Transplantation 2010;16(2):S219.
2. El-Emary M, Khabori MA, Buitron N, et al. Long Term Outcomes Of
Allogeneic Stem Cell Transplantation For Chronic Lymphocytic
Leukemia. Biology of blood and marrow transplantation: Journal of the
American Society for Blood and Marrow Transplantation
2010;16(2):S275-S276.
3. Ali AlMadhani, Alkindi S, AlZadjali S, Misquith R., Pathare A,
Krishnamoorthy R. Neonatal Screening of Newborns: Targeted Versus
Universal Approach as a Cost Effective Strategy. 15th Congress of the
European Hematology Association, Barcelona, Spain, 10-13th June,
2010.
4. Ho CH, Gravell D. Can very high value of D-dimer predict the
presence of thromboembolic disorders? Haematologica 95(Suppl
2):292, 2010. (Abstract 699). 15th Congress of the European
Hematology Association. Barcelona, Spain, June 10-13, 2010.
5. A Taher, K Musallam, A El-Beshlawy, M Karimi, S Daar, K Belhoul, ,
M Saned, G Al-Helou, G Graziadei, M Cappellini. Age-related
complications in treatment-naïve patients with thalassemia
intermedia. EHA, Barcelona, June 2010.
6. K Musallam, M Cappellini, A El-Beshlawy , M Karimi , S Daar , K
Belhoul, M Saned, C Cassaretti, A Taher. Splenectomy and
thrombosis: the case of thalassaemia intermedia. EHA, Barcelona,
June 2010
7. Farsi KA, Zadjali SA, Falahi KA, Al-Khabori MK, Pathare A,
Alkindi S. Inherited Thrombophilia In Omani Women with Recurrent
Pregnancy Loss. Blood (ASH Annual Meeting Abstracts)2010;116:5124.
8. Al-Khabori MK, Guyatt G, Minden MD, et al. A Prognostic Score of
Overall Survival In Adults with Acute Myeloid Leukemia. Blood (ASH
Annual Meeting Abstracts)2010;116:2730.
9. Al-Khabori MK, Yee K, Gupta V, et al. Validation of Monosomal
Karyotype Based Model In the Risk Stratification of Acute Myeloid
Leukemia. Blood (ASH Annual Meeting Abstracts)2010;116:2745.
10. Al-Khabori MK, Pathare A, Al Farsi K, Al Huneini M, Alkindi
S. Prevalence of Thrombophilia In Patients with Sickle Cell Disease and
Osteonecrosis. Blood (ASH Annual Meeting Abstracts)2010;116:3184.
11. Octaplex Usage one year after implementation at a tertiary care
hospital, A.Z Al Riyami, K.Roland, K.Chipperfield. Canadian society of
transfusion medicine 2010, & UBC Pathology day 2010.
12. AV. Pathare, S. Al Zadjali, R. Misquith, S. Alkindi, D
Dennison, Sahaya Pravin, Tsouria Berbar, R. Krishnamoorthy.
Pharmacogenomic variants of CYP2C9, CYP4F2 and VKORC1 and its
relation to warfarin response in native Omani patients. 15th Congress
of the European Hematology Association, Barcelona, Spain, 10-13th
June, 2010.
13. S Daar, F Al Salmi, V Ableen, W Jacob, Z Jabeen and A Pathare
T2* MRI- an effective tool to increase chelation compliance in
thalassaemia major. 15th Congress of the European Hematology
Association, Barcelona, Spain, 10-13th June, 2010
Year of
Number
Publication of
Scientific
papers
published
in the
SQU
Journal
2010
1
Number
of
scientific
papers
published
in other
scientific
journals
Number of
scientific
papers
published
as a
conference
proceeding
Number
of
scientific
paper
published
as a book
chapter
Number
of
scientific
papers
published
as a book
16
13
NIL
NIL